Cover Image
市場調查報告書

夜間多尿症:主要8個國家的市場預測

Nocturia Forecast in 8 Major Markets 2015-2025

出版商 Black Swan Analysis 商品編碼 339842
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
夜間多尿症:主要8個國家的市場預測 Nocturia Forecast in 8 Major Markets 2015-2025
出版日期: 2015年08月01日 內容資訊: 英文 38 Pages
簡介

夜間多尿症是相較大量處處可見的泌尿系統疾病,有為了排尿夜間多次醒來這樣的特徵。因另外的潛在疾病、症狀 (多尿症、前列腺肥大症 (BPH)、膀胱功能障礙等) 引起的情況變多。

本報告提供全球主要8個國家(美國、法國、德國、義大利、西班牙、英國、巴西、日本) 的夜間多尿症的發病情形相關分析、疾病概要和目前的患病人數、性別/各年代 (以5歲區分) 的詳細情況、各地區/各民族的趨勢、風險要素、疾病診斷與預後、主要的症狀和併發症、未來趨勢預測 (今後10年份) 的資訊彙整,為您概述為以下內容。

簡介

疾病的原因

風險要素與預防法

疾病診斷

各地區/各民族的差異

疾病的預後與臨床過程

疾病相關的主要共生病症/特徵

患者數的定量化技術

夜間多尿症的患病人數

夜間多尿症的主要特徵

  • 病因
  • C反應蛋白質的數值
  • 夜間排泄的頻率
  • 夜間多尿症的並存症
  • 夜間多尿症患者的BMI數值

文中的簡稱

Black Swan Analysis的其他出版刊物

以患者為基礎的聯網數據庫

以患者為基礎的服務

資料、平台的線上價格

參考文獻

附錄

圖表一覽

目錄
Product Code: NOCT0010815

Nocturia is a relatively common urological problem and involves waking up more than twice during the night to void the bladder. Nocturia tends to be caused by other underlying diseases and processes, such as polyuria, Benign Prostatic Hyperplasia (BPH) or bladder storage disorders. This report provides the current prevalent population for Nocturia across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Nocturia. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Nocturia have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Nocturia include:

  • Diabetes
  • Hypertension
  • Multiple sclerosis
  • Urinary Incontinence
  • Benign Prostatic Hyperplasia
  • Chronic Heart Failure
  • Chronic kidney disease
  • Overactive bladder
  • Alcohol consumption

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Nocturia's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Nocturia and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Nocturia's prevalent population.
  • Identify sub-populations within Nocturia which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Nocturia patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors and Prevention

Diagnosis of the Disease

Variation by Geography/ Ethnicity

Disease Prognosis and Clinical Course

Key Co-Morbid Conditions / Features associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Nocturia

Main Features of Nocturia Patients

  • Aetiology
  • C-reactive Protein Status
  • Frequency of Night-Time Voids
  • Concomitant Conditions for Nocturia
  • BMI Status of Patients with Nocturia

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables and Figures

  • Algorithm for the Definition and Treatment of Nocturia
  • Prevalence of Nocturia, total (000s)
  • Prevalence of Nocturia, males (000s)
  • Prevalence of Nocturia, females (000s)
  • Nocturia Patients by Aetiology, total (000s)
  • Nocturia Patients by CRP level, total (000s)
  • Frequency of Night-Time Voids in Patients with Nocturia, total (000s)
  • Prevalence of Diabetes in Patients with Nocturia, total (000s)
  • Prevalence of Hypertension in Patients with Nocturia, total (000s)
  • Prevalence of BPH in Patients with Nocturia, total (000s)
  • Prevalence of CHF in Patients with Nocturia, total (000s)
  • Prevalence of Urinary Incontinence in Patients with Nocturia, total (000s)
  • Prevalence of Multiple Sclerosis in Patients with Nocturia, total (000s)
  • BMI Status of Patients with Nocturia, total (000s)
  • Abbreviations and Acronyms used in the Report
  • USA Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • USA Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • France Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • France Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Germany Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Germany Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Italy Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Italy Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Spain Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Spain Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Nocturia by 5-yr age cohort, females (000s)
  • Japan Prevalence of Nocturia by 5-yr age cohort, males (000s)
  • Japan Prevalence of Nocturia by 5-yr age cohort, females (000s)
Back to Top